Nektar Therapeutics (NKTR) Exchange Rate Effect (2010 - 2025)
Nektar Therapeutics (NKTR) posted quarterly Exchange Rate Effect of $1000.0 for Q3 2025, up 103.57% year-over-year from $491.23 in Q3 2024, and down 83.33% quarter-over-quarter from $6000.0 in Q2 2025.
Nektar Therapeutics (NKTR) Exchange Rate Effect (2010 - 2025) Analysis & Trends
Nektar Therapeutics' Exchange Rate Effect history runs 16 years deep, the most recent figure standing at $1000.0 for Q3 2025.
- In Q3 2025, Exchange Rate Effect rose 103.57% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $7000.0 (up 133.33% YoY), while the FY2025 annual figure was $6000.0, up 250.0% from the prior year.
- Exchange Rate Effect for Q3 2025 stood at $1000.0, down from $6000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $107000.0 in Q2 2023, with the low at -$295000.0 in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$8000.0 (2024), against an average of -$18684.2.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect tumbled 1080.0% in 2022, then soared 700.0% in 2025.
- Nektar Therapeutics' Exchange Rate Effect stood at -$10000.0 in 2021, then jumped by 650.0% to $55000.0 in 2022, then slumped by 85.45% to $8000.0 in 2023, then soared by 312.5% to $33000.0 in 2024, then sank by 96.97% to $1000.0 in 2025.
- Business Quant data shows NKTR's Exchange Rate Effect at $1000.0 in Q3 2025, $6000.0 in Q2 2025, and -$1000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Nektar Therapeutics | 1.49 Bn | 919.46 Mn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | -98,000.00 |
| Sep 30, 2023 | -98,000.00 |
| Jun 30, 2023 | 107,000.00 |
| Jun 30, 2023 | 107,000.00 |